InMed Pharmaceuticals (INM) Gross Margin Growth (1y) (2022 - 2025)
InMed Pharmaceuticals (INM) Gross Margin Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 128.00 |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -22.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -543.00 |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | -9.00 |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 2,054.00 |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -8.00 |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -35,372.00 |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -257.00 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 4,028.00 |
| 10 | InMed Pharmaceuticals | 6.12 Mn | 875,830.32 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,900.00 |
| Sep 30, 2025 | -302.00 |
| Jun 30, 2025 | 787.00 |
| Mar 31, 2025 | -1,076.00 |
| Dec 31, 2024 | 1,532.00 |
| Sep 30, 2024 | 3,666.00 |
| Jun 30, 2024 | -3,163.00 |
| Mar 31, 2024 | 607.00 |
| Dec 31, 2023 | -178.00 |
| Sep 30, 2023 | 15,542.00 |
| Jun 30, 2023 | 1,944.00 |
| Mar 31, 2023 | -4,026.00 |
| Dec 31, 2022 | -1,416.00 |